1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Ainuovirine Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 Hospital
  • 1.3.3 Retail
  • 1.3.4 Online
• 1.4 Market Analysis by Specification
  • 1.4.1 Overview: Global Ainuovirine Consumption Value by Specification: 2021 Versus 2025 Versus 2032
  • 1.4.2 8mg/capsule
  • 1.4.3 12 mg/capsule
• 1.5 Market Analysis by Dosage form
  • 1.5.1 Overview: Global Ainuovirine Consumption Value by Dosage form: 2021 Versus 2025 Versus 2032
  • 1.5.2 Tablets
  • 1.5.3 Powder
• 1.6 Market Analysis by Application
  • 1.6.1 Overview: Global Ainuovirine Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.6.2 Treatment of HIV-1 infection
  • 1.6.3 Antiviral Therapy
  • 1.6.4 Others
• 1.7 Global Ainuovirine Market Size & Forecast
  • 1.7.1 Global Ainuovirine Consumption Value (2021 & 2025 & 2032)
  • 1.7.2 Global Ainuovirine Sales Quantity (2021-2032)
  • 1.7.3 Global Ainuovirine Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 Jiangsu Aidea Pharmaceutical
  • 2.1.1 Jiangsu Aidea Pharmaceutical Details
  • 2.1.2 Jiangsu Aidea Pharmaceutical Major Business
  • 2.1.3 Jiangsu Aidea Pharmaceutical Ainuovirine Product and Services
  • 2.1.4 Jiangsu Aidea Pharmaceutical Ainuovirine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Jiangsu Aidea Pharmaceutical Recent Developments/Updates
• 2.2 Yangzhou Aidea Pharmaceutical
  • 2.2.1 Yangzhou Aidea Pharmaceutical Details
  • 2.2.2 Yangzhou Aidea Pharmaceutical Major Business
  • 2.2.3 Yangzhou Aidea Pharmaceutical Ainuovirine Product and Services
  • 2.2.4 Yangzhou Aidea Pharmaceutical Ainuovirine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 Yangzhou Aidea Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Ainuovirine by Manufacturer

• 3.1 Global Ainuovirine Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global Ainuovirine Revenue by Manufacturer (2021-2026)
• 3.3 Global Ainuovirine Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of Ainuovirine by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 Ainuovirine Manufacturer Market Share in 2025
  • 3.4.3 Top 6 Ainuovirine Manufacturer Market Share in 2025
• 3.5 Ainuovirine Market: Overall Company Footprint Analysis
  • 3.5.1 Ainuovirine Market: Region Footprint
  • 3.5.2 Ainuovirine Market: Company Product Type Footprint
  • 3.5.3 Ainuovirine Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Ainuovirine Market Size by Region
  • 4.1.1 Global Ainuovirine Sales Quantity by Region (2021-2032)
  • 4.1.2 Global Ainuovirine Consumption Value by Region (2021-2032)
  • 4.1.3 Global Ainuovirine Average Price by Region (2021-2032)
• 4.2 North America Ainuovirine Consumption Value (2021-2032)
• 4.3 Europe Ainuovirine Consumption Value (2021-2032)
• 4.4 Asia-Pacific Ainuovirine Consumption Value (2021-2032)
• 4.5 South America Ainuovirine Consumption Value (2021-2032)
• 4.6 Middle East & Africa Ainuovirine Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global Ainuovirine Sales Quantity by Type (2021-2032)
• 5.2 Global Ainuovirine Consumption Value by Type (2021-2032)
• 5.3 Global Ainuovirine Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global Ainuovirine Sales Quantity by Application (2021-2032)
• 6.2 Global Ainuovirine Consumption Value by Application (2021-2032)
• 6.3 Global Ainuovirine Average Price by Application (2021-2032)

7 North America

• 7.1 North America Ainuovirine Sales Quantity by Type (2021-2032)
• 7.2 North America Ainuovirine Sales Quantity by Application (2021-2032)
• 7.3 North America Ainuovirine Market Size by Country
  • 7.3.1 North America Ainuovirine Sales Quantity by Country (2021-2032)
  • 7.3.2 North America Ainuovirine Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe Ainuovirine Sales Quantity by Type (2021-2032)
• 8.2 Europe Ainuovirine Sales Quantity by Application (2021-2032)
• 8.3 Europe Ainuovirine Market Size by Country
  • 8.3.1 Europe Ainuovirine Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe Ainuovirine Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific Ainuovirine Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific Ainuovirine Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific Ainuovirine Market Size by Region
  • 9.3.1 Asia-Pacific Ainuovirine Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific Ainuovirine Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America Ainuovirine Sales Quantity by Type (2021-2032)
• 10.2 South America Ainuovirine Sales Quantity by Application (2021-2032)
• 10.3 South America Ainuovirine Market Size by Country
  • 10.3.1 South America Ainuovirine Sales Quantity by Country (2021-2032)
  • 10.3.2 South America Ainuovirine Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa Ainuovirine Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa Ainuovirine Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa Ainuovirine Market Size by Country
  • 11.3.1 Middle East & Africa Ainuovirine Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa Ainuovirine Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 Ainuovirine Market Drivers
• 12.2 Ainuovirine Market Restraints
• 12.3 Ainuovirine Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Ainuovirine and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Ainuovirine
• 13.3 Ainuovirine Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Ainuovirine Typical Distributors
• 14.3 Ainuovirine Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Ainuovirine market size was valued at US$ 43.32 million in 2025 and is forecast to a readjusted size of US$ 119 million by 2032 with a CAGR of 9.9% during review period.
In 2025, global Enovelin production reached approximately 460,000 units.Enovelin is a novel small-molecule antiviral agent primarily used for the treatment of viral infectious diseases, with potential applications particularly in respiratory viruses and other RNA virus infections. Its mechanism of action generally involves inhibiting key enzymes required for viral replication or interfering with viral nucleic acid synthesis, thereby blocking viral replication and spread within host cells.
Compared with traditional antiviral drugs, enovelin demonstrates certain advantages in terms of sustained efficacy, safety, and resistance control, while also offering convenient oral administration and high bioavailability. In clinical studies or applications, the drug has shown favorable antiviral activity and tolerability, indicating its potential to establish a role in antiviral therapy.Overall, as a novel antiviral candidate, enovelin shows promising prospects in addressing viral infections.
Ainuovirine (Enovelin), as a next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) independently developed in China, is primarily positioned in the HIV antiviral treatment market. With the global population living with HIV remaining at a high level, the demand for antiretroviral therapy (ART) continues to be stable and steadily growing, particularly in developing countries and emerging markets, where there is a strong need for new drugs with high efficacy, safety, and low resistance. Ainuovirine demonstrates strong antiviral activity, low cross-resistance, and fewer drug–drug interactions, providing a differentiated competitive advantage within existing treatment regimens.
From a competitive perspective, the current HIV treatment market is dominated by integrase strand transfer inhibitors (INSTIs) and traditional NNRTIs (such as efavirenz). However, some of these drugs are associated with metabolic side effects or resistance issues, leading to renewed interest in next-generation NNRTIs. As a domestically developed innovative drug, ainuovirine was approved for marketing in 2021 and has been included in treatment guidelines and reimbursement systems, facilitating its rapid uptake in the Chinese market. In addition, its once-daily oral administration and favorable tolerability provide advantages in long-term chronic disease management.
This report is a detailed and comprehensive analysis for global Ainuovirine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ainuovirine market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Ainuovirine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Ainuovirine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Ainuovirine market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ainuovirine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ainuovirine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jiangsu Aidea Pharmaceutical, Yangzhou Aidea Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ainuovirine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hospital
Retail
Online
Market segment by Specification
8mg/capsule
12 mg/capsule
Market segment by Dosage form
Tablets
Powder
Market segment by Application
Treatment of HIV-1 infection
Antiviral Therapy
Others
Major players covered
Jiangsu Aidea Pharmaceutical
Yangzhou Aidea Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ainuovirine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ainuovirine, with price, sales quantity, revenue, and global market share of Ainuovirine from 2021 to 2026.
Chapter 3, the Ainuovirine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ainuovirine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ainuovirine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ainuovirine.
Chapter 14 and 15, to describe Ainuovirine sales channel, distributors, customers, research findings and conclusion.